丹麦乳腺癌协作组Skagen试验1中2705例放疗计划质量评估
该研究基于DBCG Skagen试验1中前瞻性上传的2705例乳腺癌患者放疗计划,分析辅助局部区域放疗的质量。结果显示方案依从性高,两个随机分组间计划无显著差异;非门控计划较呼吸门控计划肺和心脏剂量显著更高。
要点
- DBCG Skagen试验1中2705例放疗计划方案依从性高
- 50 Gy与40 Gy两组随机分组间计划剂量学无显著差异
- 非门控计划较呼吸门控计划肺和心脏剂量显著更高
核心结论
- DBCG Skagen试验1中放疗计划方案依从性高,两个随机分组间治疗计划无差异。
研究设计与样本
- 2015至2021年纳入2963例保乳术后或乳房切除术后接受辅助局部区域放疗的乳腺癌患者,随机分配至50 Gy/25次或40 Gy/15次,瘤床推量采用同步整合推量。
主要发现
- 分析来自4个国家14个中心的2705例患者放疗计划,占符合方案患者的94%。
- 1407例接受保乳手术,1298例接受乳房切除术,437例接受同步整合推量。
- 随机分组平衡:50 Gy组1329例,40 Gy组1376例。
- 所有计划靶区勾画均遵循ESTRO指南,随机分组间勾画体积及中心间差异无显著差异。
- 方案约束依从性总体较高,但50 Gy计划的热点剂量依从性高于40 Gy计划,因40 Gy组高剂量约束更严格。
关键数值与推荐
- 放疗剂量方案为50 Gy/25次 versus 40 Gy/15次,瘤床推量采用同步整合推量。
- 靶区勾画遵循ESTRO指南。
- 方案约束依从性总体较高;40 Gy组高剂量约束较50 Gy组更严格。
临床怎么用
- 乳腺癌辅助局部区域放疗中应遵循ESTRO指南进行靶区勾画。
- 呼吸门控技术可显著降低肺和心脏剂量,非门控计划肺和心脏剂量更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Based on prospectively uploaded treatment plans, a comprehensive analysis of the radiation therapy (RT) in the DBCG Skagen trial 1 is presented. METHODS: From 2015 to 2021, 2963 breast cancer patients referred to adjuvant locoregional breast cancer RT after breast conserving surgery (BCS) or mastectomy were randomised to 50 Gy/25 fractions versus 40 Gy/15 fractions. Tumour-bed boost was simultaneous integrated boost (SIB). Delineated structure volumes were per ESTRO guidelines. Dosimetric data were obtained from the individual treatment plans. RESULTS: RT treatment plans from 2705 patients treated at 14 centres in 4 countries were analysed corresponding to 94 % of the per protocol patients. Overall, 1407 had BCS, 1298 had mastectomy, and 437 had SIB. The randomisation was balanced: 1329 (50 Gy) versus 1376 (40 Gy). All plans had target volume delineations per ESTRO guidelines. No significant differences were observed regarding delineated volumes nor regarding inter-centre variations per randomisation arm. Compliance to protocol constraints was generally high, however, the "hot-spot" dose compliance was higher in 50 Gy plans compared to 40 Gy plans due to stricter high dose constraints for the 40 Gy arm. The minimum coverage of target volumes was similar per randomisation arms. Respiratory gating technique was used in 83 % of the patients. When divided into subgroups per laterality and breathing technique, significantly higher lung and heart doses were detected in non-gated compared to gated plans. CONCLUSION: A high degree of protocol compliance was documented in the DBCG Skagen trial 1. No differences were observed among the treatment plans in the two randomisation arms.
引用
- Thomsen MS, Lorenzen EL, Alsner J, et al. Quality assessment of 2705 treatment plans in the randomised Danish Breast Cancer Group Skagen trial 1. Radiother Oncol. 2025. PMID: 40962062. doi:10.1016/j.radonc.2025.111142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。